PICO Portalanswers from OpenAlex & ORCID
Andrew V. Kossenkov
ResearcherPublications, citations & collaboration network
Andrew V. Kossenkov is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Andrew V. Kossenkov have?
PICO Portalindexed works
Andrew V. Kossenkov has 804 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrew V. Kossenkov have?
PICO Portalcitation count
Andrew V. Kossenkov has 19,188 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Andrew V. Kossenkov?
PICO Portalh-index
Andrew V. Kossenkov has an h-index of 73 in OpenAlex.
What is the i10-index of Andrew V. Kossenkov?
PICO Portali10-index
Andrew V. Kossenkov has an i10-index of 199 in OpenAlex.
What is the ORCID of Andrew V. Kossenkov?
PICO Portalorcid
The ORCID for Andrew V. Kossenkov is on the source record.
What is the OpenAlex record for Andrew V. Kossenkov?
PICO Portalopenalex
The OpenAlex for Andrew V. Kossenkov is on the source record.
What are the most-cited papers on Andrew V. Kossenkov?
PICO Portalmost cited works
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine, George A. Dominguez, Je‐In Youn, Andrew V. Kossenkov, Sridevi Mony, Kevin Alicea-Torres, Evgenii N. Tcyganov, Ayumi Hashimoto, Yulia Nefedova, Cindy Lin, Simona Partlová, Alfred L. Garfall, Dan T. Vogl, Xiaowei Xu, Stella C. Knight, George Malietzis, Gui Han Lee, Evgeniy Eruslanov, Steven Μ. Albelda, Xianwei Wang, Jawahar L. Mehta, Meenakshi Bewtra, Anil K. Rustgi, Neil Hockstein, Robert Witt, Gregory A. Masters, Brian Nam, Denis A. Smirnov, Manuel A. Sepúlveda, Dmitry I. Gabrilovich
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Benjamin G. Bitler, Katherine M. Aird, Azat Garipov, Hua Li, Michael Amatangelo, Andrew V. Kossenkov, D. Schultz, Qin Liu, Ie‐Ming Shih, José R. Conejo-García, David W. Speicher, Rugang Zhang
Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation
Yumei He, Xing Li, Michela Perego, Yulia Nefedova, Andrew V. Kossenkov, Erik A. Jensen, Valerian E. Kagan, Yufeng Liu, Shuyu Fu, Qing‐Jian Ye, Yanhong Zhou, Lai Wei, Dmitry I. Gabrilovich, Jie Zhou